Skip to main content
Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
1.480
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.520
+0.040 (2.70%)
Pre-market: Jul 22, 2024, 7:05 AM EDT

Atai Life Sciences Revenue

Atai Life Sciences had revenue of $277.00K in the twelve months ending March 31, 2024, with 2.97% growth year-over-year. In the year 2023, Atai Life Sciences had annual revenue of $314.00K with 34.76% growth.

Revenue (ttm)
$277.00K
Revenue Growth
+2.97%
P/S Ratio
894.44
Revenue / Employee
$3,337
Employees
83
Market Cap
247.76M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.00K81.00K34.76%
Dec 31, 2022233.00K-20.14M-98.86%
Dec 31, 202120.38M--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Codexis 74.23M
AVITA Medical 51.50M
Utah Medical Products 49.04M
Nanobiotix 40.23M
Zevra Therapeutics 28.01M
Senseonics Holdings 23.30M
Profound Medical 5.33M
Immutep 4.58M
Revenue Rankings

ATAI News

More News